MSFBX
Price
$26.25
Change
+$0.52 (+2.02%)
Updated
Jul 2 closing price
Net Assets
1.04B
RWICX
Price
$80.32
Change
-$0.05 (-0.06%)
Updated
Jul 2 closing price
Net Assets
159.53B
Interact to see
Advertisement

MSFBX vs RWICX

MSFBX vs RWICX Comparison Chart in %
View a ticker or compare two or three
VS
MSFBX vs. RWICX commentary
Jul 06, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MSFBX is a Buy and RWICX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RWICX has more cash in the bank: 160B vs. MSFBX (1.04B). RWICX pays higher dividends than MSFBX: RWICX (1.08) vs MSFBX (0.20). MSFBX was incepted earlier than RWICX: MSFBX (25 years) vs RWICX (24 years). MSFBX (1.21) is less costly to investors than RWICX (1.06). RWICX is a more actively managed with annual turnover of: 44.00 vs. MSFBX (35.00). RWICX has a lower initial minimum investment than MSFBX: RWICX (250) vs MSFBX (1000). RWICX annual gain was more profitable for investors over the last year : 15.30 vs. MSFBX (-24.52). RWICX return over 5 years is better than : 30.81 vs. MSFBX (-20.58).
MSFBXRWICXMSFBX / RWICX
Total Expense Ratio1.211.06114%
Annual Report Gross Expense Ratio1.211.06114%
Fund Existence25 years24 years-
Gain YTD-8.47314.041-60%
Front Load5%N/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets1.04B160B1%
Annual Yield % from dividends0.201.0818%
Returns for 1 year-24.5215.30-160%
Returns for 3 years-18.4146.89-39%
Returns for 5 years-20.5830.81-67%
Returns for 10 years27.0196.7828%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
NECOX22.350.35
+1.59%
Natixis Oakmark C
AHSAX26.170.35
+1.36%
Alger Health Sciences A
FSTLX40.310.54
+1.36%
Federated Hermes MDT Large Cap Value R6
ACSRX34.190.18
+0.53%
Invesco Comstock R
MISGX13.49-0.09
-0.66%
Meridian Small Cap Growth Investor